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Julie P SmithAbstract
This introduction to a special issue on the economics of breastfeeding draws attention to the lack of economic
justice for women.
Human milk is being bought and sold. Commodifying and marketing human milk and breastfeeding risk
reinforcing social and gender economic inequities. Yet there are potential benefits for breastfeeding, and some of
the world’s poorest women might profit. How can we improve on the present situation where everyone except the
woman who donates her milk benefits?
Breastfeeding is a global food production system with unsurpassed capacity to promote children’s food security
and maternal and child health, but it is side-lined by trade negotiators who seek instead to expand world markets
for cow’s milk-based formula. Regulators focus on potential risks of feeding donated human milk, rather than on
health risks of exposing infants and young children to highly processed bovine milk. Similarly, policymakers aspire
to provide universal health care access that may be unaffordable when two thirds of the world’s children are not
optimally nourished in infancy, resulting in a global double burden of infectious and chronic disease. Universal
breastfeeding requires greater commitment of resources, but such investment remains lacking despite the cost
effectiveness of breastfeeding protection, support and promotion in and beyond health services. Women invest
substantially in breastfeeding but current policy - epitomised by the G20 approach to the ‘gender gap’ - fails to
acknowledge the economic value of this unpaid care work. Economic incentives for mothers to optimally breastfeed
are dwarfed by health system and commercial incentives promoting formula feeding and by government fiscal policies
which ignore the resulting economic costs.
‘The market’ fails to protect breastfeeding, because market prices give the wrong signals. An economic approach to the
problem of premature weaning from optimal breastfeeding may help prioritise global maternity protection as the
foundation for sustainable development of human capital and labour productivity. It would remove fiscal subsidies for
breast milk substitutes, tax their sale to recoup health system costs, and penalise their free supply, promotion and
distribution. By removing widespread incentives for premature weaning, the resources would be available for the world
to invest more in breastfeeding.
Keywords: Breast feeding/economics, Infant formula, Formula feeding, Cost-benefit analysis, Cost of illness, Health
priorities, Health promotion/economics, Child health, Infant mortality, National health programs/economics, Maternity
leave, Maternal employmentBackground
It was recently reported that a major US retailer was
considering selling human milk [1]. Though it turned
out to be a hoax, the news story highlights the increas-
ing relevance of market economics to feeding infants
and young children, and points to some challenging is-
sues policymakers must tackle.
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to improve a situation ‘where everyone except the woman
who donates her milk benefits’ ([2], p 66).Breastfeeding, and the global spread of markets
Women’s ability to decide to breastfeed and to practice
it optimally is increasingly affected by globalisation of
food and food marketing systems, and greater maternal
participation in labour markets through paid employ-
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practice and mammalian biology, exert greater influence,
including on child-feeding practices; especially, the mar-
ket share of breastmilk substitutes expands.
Trade is conventionally seen as the lynchpin of global
food security, and world trade in infant and young child
milk formula and baby food is booming in emerging
economies in Asia and Latin America. Global sales of
baby foods - mainly bovine milk-based formulas - rose
from US$18 billion in 1999 to US$58 billion in 2013,
and are forecast to rise to US$89 billion by 2017 [3]. Yet
it is wrong to assume that the current international
trade and investment framework will improve food se-
curity for infants and young children, as it fails to priori-
tise optimal breastfeeding, public health, and the human
rights of mothers and children [4]. Breastfeeding is itself
a global ‘food system’ with unsurpassed capacity to pro-
mote food security and health for infants and young
children; yet it is too frequently side-lined by trade nego-
tiators chasing national competitive advantage in selling
milk formula.Trade in milk formula also fails to optimise
human development due to the significant cognitive de-
velopment disadvantage of babies fed infant formula be-
fore six months compared to those exclusively breastfed
[5]; the deficit from this early life exposure to subopti-
mal nutrition is akin to low level pre-natal lead exposure
in its effects on countries’ educational achievement [6],
yet effects on the population’s dietary quality – and on
future chronic disease and labour productivity – are in-
creasingly left out of consideration in trade agreements [7].
The paper by Libby Salmon in this special issue identi-
fies the public policy conflicts between international
trade and optimal breastfeeding promotion and shows
how more integrated and balanced policies could result
from applying a food security analytical framework to
the challenge of ensuring optimal infant and young child
nutrition [8]. For example, food security encompasses
accessibility. For infants and young children, this means
accessing human milk and breastfeeding. Can working
mothers and their infants access breastfeeding if paid
maternity leave is not available or if work arrangements
serve as a barrier to breastfeeding?
Likewise, should health care systems fail to finance ‘ad-
equate nutrition’ for infants but rely instead solely on
the generosity of mothers? In some countries, human
milk is available for all medically vulnerable infants via
publicly funded hospital milk banks [9,10]. In other
countries, privately insured mothers may purchase do-
nated human milk accessed through milk banks, while
the infants of the uninsured may miss out on their
mammalian birth right. Governments provide fiscal and
regulatory incentives to make therapeutic human blood
products widely and safely available, yet few health sys-
tems encourage institutions to provide human milk forsick or hospitalised infants To date, the main regulatory
policy responses to the various forms of trade in human
milk focus on warning of potential risks of transferring
harmful bacteria or virus or illicit drugs or medications
through donor milk given to vulnerable infants [11]. Strong
public condemnation by health authorities of milk sharing
and trading prompts the question of whether there is a
double standard, even conflicts of interest; why are the
comparable health risks of feeding infants and young
children bovine–based milk formula not also consist-
ently and vocally highlighted by the authorities, and why
are mothers considered incompetent to make informed
choices to purchase human milk [12]? George Kent’s
paper on the global regulation of infant formula argues
that regulators fail to require adequate information on the
risks of exposure to commercial milk formulas [13],
and challenges them to properly justify the unsubstanti-
ated presumption that these formulas are ‘safe’ and pro-
vide ‘adequate nutrition’ as the sole food for infants.
When human milk is an accessible alternative, by what
standard is infant formula judged nutritionally ‘adequate’
by food safety regulators?
Selling mothers’ milk
The growing commodification of human milk and breast-
feeding creates complex and controversial policy problems
in eliciting and allocating its supply. For the past century,
the operating business model for human milk sharing has
been the ‘gift economy’, with the mother who provides the
milk being unremunerated [14,15]. However, technological
change is facilitating the trading and exchange of human
milk and employment in wet-nursing [2,16-20], with hu-
man milk now collected, processed and sold as a commer-
cial enterprise [21].
Whether these niche markets in human milk widen or,
alternatively, discourage infants’ and mothers’ access to
breastfeeding depends partly on the social and institu-
tional context, and on how health regulatory policy ad-
dresses the market failures and inequities associated
with the current incentives for formula feeding [22]. For
example, as well as making human milk available to
more babies, greater trading and exchange of human
milk could mean greater societal recognition of the eco-
nomic value of breastfeeding, and might enable human
milk or breastfeeding to better compete with bovine
milk-based substitutes. Indeed, women – as sole pro-
ducers of this uniquely valuable ‘health food’ - can earn
a decent livelihood as wet-nurses [23], or supplement
their often meagre income by selling their surplus milk
through the newly emerging markets and online trading
systems [16].
On the other hand, markets for human milk could
simply mean new avenues for the rich and strong to exploit
the poor and vulnerable, while reducing some women’s
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their own infants. For example, a report of a reluctant sur-
rogate mother in India who was required to be a wet nurse
and nanny under contract to a Canadian couple illustrates
the potential unequal power dynamics and patriarchal or
social class structures that already underpin markets in ‘re-
productive services’ [24]. How might national authorities
respond to the international trafficking of women coerced
into providing reproductive services such as wet-nursing?
One wonders also, to what extent is consumer demand for
human milk and wet-nurses underpinned by the lack of ad-
equate maternity leave to enable optimal breastfeeding in
countries such as the US or China?
Breastfeeding minimises health care costs and enhances
equity, but who pays for the free lunch?
Well known for preventing infectious illness in infants,
young children and protecting the health of their mothers,
breastfeeding also promotes development of the immune
system and cognitive development, and influences later life
chronic disease risk, and contributes to maternal reproduct-
ive health in many ways [5,25-29]. Even where geographically
or socially disadvantaged populations are poorly served by
health services, breastfeeding is a universally accessible
‘health service’ and a tool for equity in child health [30], and
can promote rights to reproductive health for even the poor-
est women, including through adequate birth spacing [31].
There are calls worldwide for universal access to
healthcare services (such as by the Lancet Global Health
Commission [32]). However, the recent dramatic decline
in breastfeeding in Asian Pacific countries, notably in
China [4], poses the question of whether the world can
afford universal health care without first protecting and
promoting universal breastfeeding. Based on estimates
of the costs of artificial infant feeding in developed
countries [33-41], health care systems in low- and mid-
dle-income countries will carry a heavy double burden
of infectious illness and chronic disease if breastfeeding
is not urgently protected from the ‘white gold rush’ of
formula sales underway in the Asia Pacific region.
However, universal support for women to succeed in
breastfeeding requires investment, to address the consid-
erable incentives against it. Although support for breast-
feeding is widely acknowledged to be one of the most
cost-effective ‘interventions’ [42], it is one of the most
underfunded. The resourcing and implementation of the
WHO/UNICEF Global Strategy for Infant and Young
Child Feeding remains weak at the global and country
level despite lip service paid to its value in international
and national policy statements [43]. The paper by Holla
and colleagues in this issue includes a tool estimating
the cost of universal implementation of the Global Strat-
egy [44]. This research reinforces awareness that invest-
ing in breastfeeding also directs resources to the world’spoorest women, and helps address gender equity, while
contributing to a sustainable food, nutrition and health
system for the world’s most vulnerable infants and young
children.
Incentives for breastfeeding
There is a growing interest in offering financial incen-
tives to motivate health behaviour change. We can learn
much from companies about how to market effectively
to mothers [45]. Formula manufacturers are very suc-
cessful in using ‘incentives’ to motivate, and connect
with mothers. It has been posited that as a social mar-
keting technique, financial incentives may be relevant to
increasing breastfeeding [46].
From an economic perspective though, the critical
issue is the less visible incentives, for or against breast-
feeding, operating in health care systems and institu-
tions, and created by labour markets and employment
arrangements. While most such research has focused on
health care impact on mothers’ behaviours [47-49], and
the unintended consequences [50,48], the central ques-
tion is, what incentives for breastfeeding protection, sup-
port and promotion are faced by the other stakeholders
in infant and young child feeding, including formula
companies, governments, and health care providers?
Market mechanisms fail to protect breastfeeding be-
cause of the distorted incentive structures that influence
infant feeding decisions, and the corresponding lack of a
commercially motivated ‘Mothers’ Milk Incorporated’ to
protect, promote and support breastfeeding [22]. The
paper by Elien Rouw and colleagues [51] well illustrates
the perverse economic incentives that operate for mothers,
hospitals and health care professionals in Germany, who
face significant financial penalties for breastfeeding or its
protection, support or promotion. Public policy on the
other hand, may neglect breastfeeding because its economic
worth is rarely measured in economic terms [52], and be-
cause women’s economic contribution through time spent
in breastfeeding and other unpaid care work is often dis-
counted and ignored, and, therefore, invisible [53].
The likely harm to breastfeeding from unregulated
marketing and promotion and use of breast milk substi-
tutes by government, health care institutions and indus-
try is recognised at the international level in the
existence of the International Code of Marketing of
Breast-milk Substitutes [54] and the Codex Code of Eth-
ics for International Trade in Food [55]. Yet, within
countries, the International Code is inconsistently ap-
plied, and rarely encompasses export industries, so com-
panies have little incentive to behave ethically [56].
Currently, the regulation of marketing in developed
countries and a trend to return to breastfeeding, is giv-
ing formula companies an incentive to shift their atten-
tion to developing countries in the Asia Pacific region
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or weak, and maternity protection minimal. Women are
being harnessed into formal employment by G20 policy
priorities to address ‘the gender gap’ in labour force par-
ticipation [57]. As mothers of young children also carry
an unequal burden of unpaid care work [58], time
pressed women concentrated in poorly paid jobs and
with unsupportive work conditions are particularly vul-
nerable to aggressive marketing of infant and toddler
milk formulas [59]. Boosting the market economy by
creating incentives which shrink the unpaid economy is
not economic progress [60].
The fiscal policies of all governments are strongly con-
cerned with influencing incentives and disincentives, and
tobacco and alcohol taxes are well known to affect
health behaviour [61]. Governments and international
agencies heavily subsidise vaccination programs to give
families incentives to immunise their children [51].
Breastfeeding contributes to maternal and child health
across a much wider sphere. So what incentives do gov-
ernments create for breastfeeding through their fiscal
policies?
Surprisingly, government fiscal policies worldwide pro-
vide incentives for families to use formula rather than
breastfeed optimally. For example, formula use is heavily
subsidised by governments through community welfare
programs [62]. In the US, the Special Supplemental Nutri-
tion Program for Women, Infants, and Children (WIC)
program purchases more than half of all formula sold, po-
tentially underwriting the price of formula worldwide
[3,63]. In Australia, infant milk formula is exempt from
the national goods and services tax, yet lactation aids such
as breast pumps are taxed at 10%. In China, formula sales
are promoted by government subsidies which aim to de-
velop the domestic industry and to encourage research
into new formula products [64,65]. Labbok and colleagues
have noted in this journal [66] that advocacy for a Breast-
feeding Budget was a key policy action for financing gen-
der equality at the 2008 UN Commission on the Status of
Women [67]. Yet government-supported breastfeeding
programs remain tiny compared to the approximate 10%
of sales spent by the industry on marketing baby food
products [68].
The availability of free formula is surely a financial dis-
incentive to protect, promote and support breastfeeding.
Incentives for formula feeding are also intrinsic to health
financing arrangements which allow training and educa-
tion for health workers to be provided by formula com-
panies. Around 60 per cent of maternity services globally
are not Baby Friendly Hospital Initiative (BFHI) designated
[62]. Such hospitals provide free formula as a matter of
course for new-borns [64,65], yet can require mothers to
purchase their own breast pump in order to continue ex-
pressing and giving milk for their hospitalised infants.Hospital decision-makers perceive BFHI accreditation,
which simply provides quality of care [12], as expensive
even though higher breastfeeding rates reduce health care
costs [33-38]. One needs to look no further than China in
2013 [69-72] or Italy in 2014 [73] to find system-wide in-
centives for maternal and child health care systems and
health professionals to promote formula, and hence, create
barriers to breastfeeding success. While health systems
and workers worldwide accept gifts, training and educa-
tion opportunities, and free product from the baby food
industry, in contravention of the International Code, how
can any token incentives for breastfeeding possibly work?
The strong commercial motivations for the promotion
and advocacy of formula feeding by companies are clear,
but it would seem that government policies, health sys-
tems and health workers reinforce, rather than redress,
the commercial incentives. As Finch and colleagues
([74], p. 982) observed with considerable understatement
in 2002, ‘improving rates of breastfeeding when formula
is free is a great challenge.’
Most importantly though, consideration of financial
incentives must also address the economic issue of women’s
opportunity cost of time, and relatedly, the employment
and workplace barriers to breastfeeding facing many
mothers around the world. Breastfeeding is not, contrary to
the rhetoric, a free good [75,76]. It has long been recognised
that women’s time and skill are essential for optimal breast-
feeding [75], and this has been shown by time use research
in Australia to be economically costly for women [77].
However, most cost-benefit studies of breastfeeding, or ini-
tiatives to promote it, fail to acknowledge the maternal time
costs of breastfeeding and the costs of breastfeeding sup-
port, as such studies are usually conducted from a narrow
health system or health provider perspective. For the right
incentives to operate in regard to feeding infants and young
children, women’s unpaid care work must be adequately
valued and resourced, and adequate paid maternity leave
and supportive employment provided for all working
women. The feminist ‘silence on suckling’ [78] needs to be
redressed by feminist economic analysis of the economic
value of women’s reproductive work including breastfeed-
ing, and strong advocacy of maternity protection not only
in the G20 countries but globally. Improving rates of breast-
feeding when the economic burden of lost earnings and
career opportunities falls heavily on the poorest women is
as much of a challenge as improving breastfeeding when
formula is free.
Researching economic aspects of breastfeeding
An economic approach to the problem of premature
weaning from optimal breastfeeding would start by re-
moving both the explicit and implicit fiscal subsidies for
the marketing, promotion and use of breast milk sub-
stitutes. The International Code would be enforced
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or subsidised supplies, and prevent industry from con-
ducting health worker training and education in for-
mula feeding. Health care services and hospitals could
be rewarded for BFHI accreditation with additional
funding to achieve a more appropriate alignment of
the health system costs and rewards of breastfeeding
protection, promotion and support. An excise tax on
sales of breast milk substitutes could be designed to
recoup the health costs of premature weaning. Com-
bined with enforcement of the International Code, this
would help correct the market failures that undermine
health institutional incentives to support breastfeed-
ing. Revenue could be used to address health system
barriers to breastfeeding support. Reflecting breast-
feeding’s long-term contribution to health and human
capital building, enhanced access to paid maternity
leave for mothers of new-borns might be funded
through appropriate combinations of general income
tax, social security or social insurance fund contribu-
tions and payroll levies, and through an international
fund created to assist countries to implement adequate
maternity protection throughout the world. This approach
to financing maternity protection would share the eco-
nomic costs of reproduction with wider society, and min-
imise incentives for employers to dismiss or not hire
women of child-bearing age. Such approaches are contro-
versial, but UNICEF data show optimal breastfeeding rates
to have been virtually stagnant for decades. Indeed, indus-
try data shows rapid expansion of milk formula sales, and
infers very substantial global declines in breastfeeding [4].
Conclusion
Research evidence and scholarly debate on the economic
aspects of breastfeeding are urgently needed to ensure
that the public policy and regulatory discussion has a
strong conceptual framework and evidence base, and
that policy formulation is not dominated and distorted
by powerful sectional interests.
Breastfeeding and expressed human milk may be given
freely by women everywhere, but that is no reason for it
to be considered of no economic value, and why women
should not profit from it. Marketisation of human milk
and breastfeeding should not reinforce and validate the
unrequited burdens and unequal care responsibilities of
the world’s long-suffering and overloaded mothers.
A sustained research focus on the economic aspects
of breastfeeding would highlight the key economic
factors and incentives that shape mothers’ decisions to
nourish and nurture a child with their milk, from the
decisions about employment or social acceptance by
individual women, to programs testing the cost and
effectiveness of financial incentives for breastfeeding
and identifying the financial and economic incentivesfor formula feeding, to evidence on the role of com-
mercial marketing in changing breastfeeding practices
and culture, to consideration of how the WHO/
UNICEF Global Strategy for Infant and Young Child
Feeding can be properly financed and implemented in
both low- and high-income countries, to the benefit of
the poor as the rich and women as well as men.
This special issue of the International Breastfeeding
Journal catalyzes a focussed discussion on the economic
influences on and consequences of breastfeeding, mothers’
milk, and premature weaning and how this links to redres-
sing ‘the gender gap’, in the hope that exploration of this
unusual topic will contribute to improved country and
international policies and practices, such as paid maternity
leave and appropriate maternal and child health care, that
better enable all women to be supported to breastfeed as
is optimal to their needs and situation.
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